🔁 Solar credits back on the table

Good evening. White House spokesperson Karoline Leavitt mentioned that the July tariff deadlines may be flexible (“liberation day” tariffs are supposedly set for July 8). Meanwhile, last week’s jobless claims came in lower than expected.

⬆︎⬇︎ 1-day change
Market data: today’s market close

WINNERS

⬆︎33.01% Core Scientific

CoreWeave is reportedly in talks to buy Core Scientific, a company that provides data centers for crypto mining and AI workloads. The two have a long-standing business relationship, with CoreWeave already committing billions in contracts to Core Scientific. A deal could be finalized in the coming weeks. [Read more]

⬆︎12.83% Enphase

Don’t count solar out just yet. Enphase, the solar tech company behind those rooftop microinverters, has been under pressure lately as the Trump administration recently slashed green energy support. But that may be changing. Republicans are now floating a version of the budget bill that could include more generous clean energy tax credits than what the House proposed. [Read more]

⬆︎5.34% McCormick

🛎️ Earnings report - Bringing the heat. McCormick, the flavor powerhouse behind brands like Frank’s RedHot and French’s, just had a solid quarter. Its financials look healthy overall, with high profit margins, a strong balance sheet, and a 2.23% dividend yield near decade highs. It’s sticking to its 2025 sales and profit goals thanks to smart cost-cutting and pricing strategies. [Read more]

⬆︎4.09% H&M

🛎️ Earnings report - Fashionably frugal. The fast-fashion heavyweight posted earnings that weren’t great, but weren’t as bad as feared. Profit fell 28%, hurt by a more expensive U.S. dollar and rising costs, but solid cost-cutting and steady local-currency sales helped cushion the blow. The company is buying back shares and still has strong liquidity. Room to maneuver is still there. [Read more]

⬆︎⬇︎ 1-day change
Market data: today’s market close

IN PARTNERSHIP WITH 1440 MEDIA

The Daily Newsletter for Intellectually Curious Readers

Join over 4 million Americans who start their day with 1440 – your daily digest for unbiased, fact-centric news. From politics to sports, we cover it all by analyzing over 100 sources. Our concise, 5-minute read lands in your inbox each morning at no cost. Experience news without the noise; let 1440 help you make up your own mind. Sign up now and invite your friends and family to be part of the informed.

Join for free today!

LOSERS

⬇︎9.56% Equinix

Burn now, earn later. Equinix, the data center powerhouse behind much of the internet’s infrastructure, updated its long-term growth plan. It now expects 5–9% annual growth in adjusted funds from operations through 2029, down from earlier 7-10%. The downgrade is tied to higher borrowing costs and big spending under its “Build Bolder” expansion plan, which aims to double capacity. [Read more]

⬇︎53.18% Altimmune

Glass half empty. Altimmune, a biotech working on liver and weight loss drugs, shared mixed results from a mid-stage trial. Its drug, pemvidutide, helped many patients with MASH (a type of liver disease), but didn’t clearly improve liver scarring. [Read more]

⬆︎⬇︎ 1-day change
Market data: today’s market close

IN PARTNERSHIP WITH EARNINGS HUB

We cover a lot of earnings in this newsletter, but only at a glance. If you want to go deeper, Earnings Hub gives you:

✅ AI-powered earnings call summaries
✅ Full transcripts & live call access
✅ Analyst ratings & corporate guidance
✅ Real-time alerts for unlimited tickers (via SMS, Email, or App)
✅ Dividend alerts, news digests & more

No more missed earnings. No more scrambling for info. Everything in one place. Check it out → Earnings Hub

EXTRA

THE END

That’s it for today’s recap. We hope you found it valuable.

• Was this email forwarded to you? Subscribe so you can stay updated on stock movers every day.

• Missed our previous newsletters? You can catch up on them here.

• Interested in advertising with us? Reply to this email, and we’ll take it from there.

FEEDBACK